sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
20-Dec-2014 21:42
US Eastern Time

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 26-50 out of 942.

<< < 1 | 2 | 3 | 4 | 5 | 6 > >>

Public Release: 8-Dec-2014
Annals of Global Health
Asbestos: An ongoing challenge to global health
Challenges to global health can evolve from policies and decisions that take years or decades to unfold. An article in the current issue of the Annals of Global Health describes the current state of asbestos use worldwide, a story that began over 100 years ago, and the real and contrived controversies regarding asbestos.

Contact: Eileen Leahy
hmsmedia@elsevier.com
732-238-3628
Elsevier Health Sciences

Public Release: 8-Dec-2014
Each dollar spent on kids' nutrition can yield more than $100 later
There are strong economic incentives for governments to invest in early childhood nutrition, reports a new paper from the University of Waterloo and Cornell University. Published for the Copenhagen Consensus Centre, the paper reveals that every dollar spent on nutrition during the first 1,000 days of a child's life can provide a country up to $166 in future earnings.

Contact: Pamela Smyth
psmyth@uwaterloo.ca
519-888-4777
University of Waterloo

Public Release: 8-Dec-2014
Rapid Ebola test is focus of NIH grant to Rutgers scientist
Rutgers researcher David Alland, working with the California biotechnology company Cepheid, has received a grant of nearly $640,000 from the National Institutes of Health to develop a rapid test to diagnose Ebola as well as other viruses that can cause symptoms similar to Ebola. Alland and Cepheid previously used technology similar to the planned Ebola test to develop a rapid test for tuberculosis that is now widely used in impoverished areas of the world.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Rob Forman
robert.forman@rutgers.edu
973-972-7276
Rutgers University

Public Release: 8-Dec-2014
Lancet
Combining insecticide sprays and bed nets 'no more effective' in cutting malaria
There is no need to spray insecticide on walls for malaria control when people sleep under treated bed nets, according to new research by Durham University and the Medical Research Council's Unit in The Gambia.
Medical Research Council

Contact: Steve Lindsay
s.w.lindsay@durham.ac.uk
44-191-334-1291
Durham University

Public Release: 8-Dec-2014
Nature Cell Biology
A pill for obesity?
Harvard Stem Cell Institute researchers at Harvard and Massachusetts General Hospital have taken what they are describing as 'the first step toward a pill that can replace the treadmill' for the control of obesity -- though it of course would not provide all the additional benefits of exercise. The researchers have already identified two compounds that can accomplish that in human cells.

Contact: B. D. Colen
bd_colen@harvard.edu
617-413-1224
Harvard University

Public Release: 5-Dec-2014
International Journal of Biomedical Engineering and Technology
Stick out your tongue
The tongue can betray signs of illness, which combined with other symptoms such as a cough, fever, presence of jaundice, headache or bowel habits, can help a physician offer a diagnosis. For people in remote areas who do not have ready access to a physician, a new diagnostic system is reported in the International Journal of Biomedical Engineering and Technology that works to combine the soft inputs of described symptoms with a digital analysis of an image of the patient's tongue.

Contact: Albert Ang
press@inderscience.com
Inderscience Publishers

Public Release: 4-Dec-2014
Nature Communications
UCLA study: To stop spread of HIV, African governments should target hot zones
To stop the spread of HIV in Africa, researchers at UCLA, using a complex mathematical model, have developed a strategy that focuses on targeting 'hot zones,' areas where the risk of HIV infection is much higher than the national average.

Contact: Mark Wheeler
mwheeler@mednet.ucla.edu
310-794-2265
University of California - Los Angeles

Public Release: 4-Dec-2014
Ebola rapid response
The National Science Foundation has awarded the first of a number of rapid response grants to advance fundamental Ebola research. The grants will support researchers seeking to answer important questions about the virus's fundamental nature, how it interacts with other substances, how it spreads, and how communication and perception affect public safety during an epidemic.
National Science Foundation

Contact: Sarah Bates
sabates@nsf.gov
703-292-7738
National Science Foundation

Public Release: 4-Dec-2014
PLOS Pathogens
Blood pressure build-up from white blood cells may cause cerebral malaria death
Intracranial hypertension -- increased blood pressure inside the head -- can predict a child's risk of death from malaria. A study published on Dec. 4 in PLOS Pathogens reports that accumulation of white blood cells impairs the blood flow out of the brain and causes blood pressure increases in mice with experimentally induced cerebral malaria.
Dana Foundation, National Institutes of Health

Contact: Ute Frevert
ute.frevert@nyumc.edu
212-263-6755
PLOS

Public Release: 4-Dec-2014
Cell
Friendly bacteria are protective against malaria
In a breakthrough study to be published on the Dec. 4 issue of the prestigious scientific journal Cell, a research team led by Miguel Soares at the Instituto Gulbenkian de Ciencia discovered that specific bacterial components in the human gut microbiota can trigger a natural defense mechanism that is highly protective against malaria transmission.
Bill and Melinda Gates Foundation, Fundano para a Ciencia e a Tecnologia, European Research Council

Contact: Ana Mena
anamena@igc.gulbenkian.pt
351-214-407-959
Instituto Gulbenkian de Ciencia

Public Release: 3-Dec-2014
Parasite researcher wins international malaria medal
Melbourne researcher professor Alan Cowman has won the Sornchai Looareesuwan Medal 2014 for his significant contributions to understanding how the malaria parasite causes disease and for his search for potential malaria vaccines.

Contact: Alan Gill
gill.a@wehi.edu.au
61-393-452-719
Walter and Eliza Hall Institute

Public Release: 3-Dec-2014
Volunteers can now help scientists seek Ebola cure in their (computer's) spare time
Beginning today, anyone can download a safe and free app that will put their computer or Android-based mobile device to work to form a virtual supercomputer to help The Scripps Research Institute screen millions of chemical compounds to identify new drug leads for treating Ebola. Meanwhile, the devices will remain fully available for normal use by their owners.

Contact: Madeline McCurry-Schmidt
madms@scripps.edu
858-784-9254
Scripps Research Institute

Public Release: 2-Dec-2014
Novel nanoparticle technology to be used to screen for Ebola virus in saliva
Ceres Nanosciences will work with George Mason University and the United States Army Medical Research Institutes of Infectious Diseases to assess the ability of the Nanotrap technology to develop a more sensitive and safer Ebola virus detection method that uses saliva instead of blood.
Bill & Melinda Gates Foundation

Contact: Michele McDonald
mmcdon15@gmu.edu
703-993-8781
George Mason University

Public Release: 1-Dec-2014
Transfusion
Experts question aspects of certain Ebola guidelines
Various guidelines for caring for patients infected with Ebola virus are being issued from different national and state public health authorities, professional societies, and individual hospitals. Experts are questioning aspects of some of the guidelines that go beyond current CDC recommendations, especially those that call for suspending certain routine lab tests.

Contact: Dawn Peters
sciencenewsroom@wiley.com
781-388-8408
Wiley

Public Release: 29-Nov-2014
Canada funds 11 new global health innovations in La Francophonie member states
Grand Challenges Canada, funded by the Government of Canada, today announced $1.2 million in funding for 11 new global health innovations implemented in member states of La Francophonie. All new projects excel in boldness and creativity and aim to address pressing health challenges, such as malaria, malnutrition and sanitation. They will help to improve maternal, newborn and child health, Canada's top development priority.
Grand Challenges Canada

Contact: Lode Roels
lode.roels@grandchallenges.ca
416-673-6570
Grand Challenges Canada

Public Release: 27-Nov-2014
Science
Secret of tetanus toxicity offers new way to treat motor neuron disease
The way that tetanus neurotoxin enters nerve cells has been discovered by UCL scientists, who showed that this process can be blocked, offering a potential therapeutic intervention for tetanus. This newly-discovered pathway could be exploited to deliver therapies to the nervous system, opening up a whole new way to treat neurological disorders such as motor neuron disease and peripheral neuropathies.
Medical Research Council, Cancer Research UK

Contact: Siobhan Pipa
siobhan.pipa@ucl.ac.uk
44-207-679-9041
University College London

Public Release: 26-Nov-2014
New England Journal of Medicine
NIAID/GSK experimental Ebola vaccine appears safe, prompts immune response
An experimental vaccine to prevent Ebola virus disease was well-tolerated and produced immune system responses in all 20 healthy adults who received it in a Phase 1 clinical trial conducted by researchers from the National Institutes of Health. The candidate vaccine, which was co-developed by the NIH's National Institute of Allergy and Infectious Diseases and GlaxoSmithKline, was tested at the NIH Clinical Center in Bethesda, Md.
NIH/National Institute of Allergy and Infectious Disease, GlaxoSmithKline

Contact: Anne A. Oplinger
aoplinger@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 25-Nov-2014
Vaccine
Powdered measles vaccine found safe in early clinical trials
A measles vaccine made of fine dry powder and delivered with a puff of air triggered no adverse side effects in early human testing and it is likely effective, according to a paper to be published Nov. 28 in the journal Vaccine. The paper is now available online.
National Institutes of Health, Bill and Melinda Gates Foundation

Contact: Robert Sievers
Bob.Sievers@colorado.edu
303-492-7943
University of Colorado at Boulder

Public Release: 25-Nov-2014
BMC Public Health
International team reveals barriers to public health data-sharing; life-saving solutions
Barriers to the sharing of public health data hamper decision-making efforts on local, national and global levels, and stymie attempts to contain emerging global health threats, an international team led by the University of Pittsburgh Graduate School of Public Health announced today.
Bill & Melinda Gates Foundation, NIH/National Institute of General Medical Sciences

Contact: Allison Hydzik
hydzikam@upmc.edu
412-647-9975
University of Pittsburgh Schools of the Health Sciences

Public Release: 25-Nov-2014
European Heart Journal
'Utter neglect' of rheumatic heart disease revealed by results from global study
Rheumatic heart disease -- the most common acquired heart disease in children in many countries of the world -- is being neglected and poorly treated, according to new findings from the Global Rheumatic Heart Disease Registry (the REMEDY study), published online in the European Heart Journal.

Contact: Emma Mason
wordmason@mac.com
European Society of Cardiology

Public Release: 24-Nov-2014
New support for structure-guided drug discovery coalition research on tropical diseases
Almost $2 million is being invested by the Bill & Melinda Gates Foundation to help fight major parasitic diseases of the developing world.
The Bill & Melinda Gates Foundation

Contact: Liam Mitchell
liam.mitchell@utoronto.ca
416-978-4672
University of Toronto

Public Release: 24-Nov-2014
International Journal of Medical Engineering and Informatics
Educating on sickle cell risk
Members of the public in sub-Saharan Africa who are carriers of the hereditary disease sickle cell disease must be educated aggressively through public health campaigns to raise awareness of the risks of parenting offspring with the disease if their partner is also a carrier, according to research published in the International Journal of Medical Engineering and Informatics.

Contact: Albert Ang
press@inderscience.com
Inderscience Publishers

Public Release: 24-Nov-2014
Nature Communications
Important element in the fight against sleeping sickness found
Researchers from Aarhus have now uncovered how parasites that cause the deadly sleeping sickness in Africa absorb an important nutrient from the human blood stream. The result may help the development of more effective drugs to fight the disease.

Contact: Christian Brix Folsted Andersen
cbfa@biomed.au.dk
45-87-15-43-56
Aarhus University

Public Release: 20-Nov-2014
ASTMH 63rd Annual Meeting
UTMB professors receive American Society of Tropical Medicine and Hygiene national awards
Scientists at the University of Texas Medical Branch were recognized with prestigious awards for their contributions in research at the annual American Society of Tropical Medicine and Hygiene meeting.

Contact: Donna Ramirez
donna.ramirez@utmb.edu
409-772-8791
University of Texas Medical Branch at Galveston

Public Release: 20-Nov-2014
A global report card: Are children better off than they were 25 years ago?
UCLA's World Policy Analysis Center has published a comprehensive analysis of children's rights in 190 countries around the world.

Contact: Carla Denly
cdenly@support.ucla.edu
310-825-6738
University of California - Los Angeles

Showing releases 26-50 out of 942.

<< < 1 | 2 | 3 | 4 | 5 | 6 > >>